- Home
- HOV vs EIKN Comparison
HOV vs EIKN Comparison
Compare HOV & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOV | EIKN |
|---|---|---|
| Founded | 1959 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 726.0M | 631.0M |
| IPO Year | 1994 | 2026 |
Fundamental Metrics
Financial Performance| Metric | HOV | EIKN |
|---|---|---|
| Price | $122.55 | $10.86 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $97.00 | $25.60 |
| AVG Volume (30 Days) | 106.2K | ★ 471.2K |
| Earning Date | 05-19-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.55 | N/A |
| Revenue | ★ $2,978,581,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.96 | N/A |
| P/E Ratio | $76.26 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $91.52 | $7.90 |
| 52 Week High | $162.06 | $16.50 |
Technical Indicators
Market Signals| Indicator | HOV | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 40.59 | 51.72 |
| Support Level | $97.80 | $10.82 |
| Resistance Level | $127.03 | $13.85 |
| Average True Range (ATR) | 7.22 | 1.14 |
| MACD | -1.28 | -0.05 |
| Stochastic Oscillator | 35.83 | 21.32 |
Price Performance
Historical ComparisonAbout HOV Hovnanian Enterprises Inc.
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations. The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments: Northeast, which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia; Southeast, which includes Florida, Georgia, and South Carolina; and West, which includes Arizona, California, and Texas. The firm generates maximum revenue from the West Segment.
About EIKN Eikon Therapeutics Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.